LMRI Company Profile and Key Details

Lumexa Imaging Holdings, Inc. Common Stock has 96.08 million shares outstanding. The public float is 22.12 million shares, elevated short interest at 9.77% of float. This equals 2.52 million shares. The short ratio is 3.53 days. Institutional investors hold 180.08% of the float. Insiders own 80.79%. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $23.00 to $9.00. The high target offers 125.27% upside. The low target suggests -11.85% downside. The mean target is $19.50. This offers 90.99% upside. Lumexa Imaging Holdings, Inc. Common Stock earnings surprise history is a mixed track record. The quarter that ended August 12, 2026, missed forecasts by 34.86%. The prior quarter beat by -83.33%. Over the last six quarters, Apple has recorded several small beats. These include -1420.0% in March 26, 2026.

Lumexa Imaging Holdings, Inc. Common Stock last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$11.42. This means the shares are trading below this model’s fair value.

Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ:LMRI) closed at $10.21 USD, gaining $0.33 (3.34%) from the previous close of $9.88. The stock is currently mid-range between its 52-week high and low $6.45 and $19.45. With a market capitalization of about $980.98 million, Lumexa Imaging Holdings, Inc. Common Stock is classified as a small-cap and shows market-like volatility (beta ~1.01). Key stats such as the average daily volume over the past year has been around 459.17 thousand shares, in line with its 52-week average. Headquartered in Raleigh, NC, Lumexa Imaging Holdings, Inc. Common Stock operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Caitlin Zulla, the company employs approximately 5,000 people and listed since December 11, 2025. Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States.

Our AI price prediction model suggests that Lumexa Imaging Holdings, Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -11.66%, with price expected at $9.02 by October 09, 2026, within a range of $8.70 to $9.34 3-Month Outlook: Projected fall of -93.73%, reaching $0.64 by December 24, 2026, with a range of $0.38 to $0.92. 1-Year Outlook: Projected loss of -42.02%, with price at $5.92 by September 24, 2027, within a range of $4.44 to $6.54.

currently trading near 52-week highs band. Valuation shows Lumexa Imaging Holdings, Inc. Common Stock trading at a premium to the broader market with a P/E of -27.17. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $19.50, suggesting 90.99% upside. Our AI forecast model points to short-term weakness (-11.66% over two weeks), a medium-term fall (-93.73% over three months), and a longer-term loss (-42.02% over one year), with expected trading ranges indicating moderate volatility.

Lumexa Imaging Holdings, Inc. Common Stock trades at a P/E ratio of -27.17, slightly below the S&P 500 average, with a price-to-sales ratio of 0.94 and a price-to-book ratio of 1.59 suggesting the stock is closer to book value. The P/FCF stands at 30.81, also above market averages.